P1156: magnify phase 3b study of lenalidomide + rituximab (r2) followed by maintenance in relapsed/refractory indolent non-hodgkin lymphoma: complete induction phase analysis
HemaSphere（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined